Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 13, Number 11, November 2002   [Index by Author] 
Other Issues: Previous Next  

Down News
Down Editorials
Down Review
Down Breast cancer
Down Gynecologic tumors
Down Gastrointestinal tumors
Down Hematologic malignancies
Down Urogenital tumors
Down Miscellaneous tumors
Down Phase I and pharmacokinetics
Down Clinical case
Down Letters to the Editor
Down Book reviews


[Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

News Back

President Bush nominates top White House aide as FDA chief
Ann Oncol 2002 13: 1693-1694; doi:10.1093/annonc/mdf348 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Editorials Back

J. S. Tobias and R. D. Hamilton
Prospective clinical trials as a model for patient-centred care
Ann Oncol 2002 13: 1695-1696; doi:10.1093/annonc/mdf341 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

D. E. Brenner
New paradigms in oncological therapeutics: redefining combination chemotherapy
Ann Oncol 2002 13: 1697-1698; doi:10.1093/annonc/mdf349 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Review Back

J. Goffin and E. Eisenhauer
DNA methyltransferase inhibitors—state of the art
Ann Oncol 2002 13: 1699-1716; doi:10.1093/annonc/mdf314 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Breast cancer Back

E. Heidemann, H. Stoeger, R. Souchon, W.-D. Hirschmann, H. Bodenstein, C. Oberhoff, J. T. Fischer, M. Schulze, M. Clemens, R. Andreesen, M. Mahlke, M. König, A. Scharl, K. Fehnle, and M. Kaufmann
Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial
Ann Oncol 2002 13: 1717-1729; doi:10.1093/annonc/mdf306 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

G. Mustacchi, M. Muggia, S. Milani, R. Ceccherini, M. L. Leita, and C. Dellach
A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer
Ann Oncol 2002 13: 1730-1736; doi:10.1093/annonc/mdf290 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

H. Gogas, C. Papadimitriou, H. P. Kalofonos, D. Bafaloukos, G. Fountzilas, D. Tsavdaridis, A. Anagnostopoulos, A. Onyenadum, P. Papakostas, T. Economopoulos, C. Christodoulou, P. Kosmidis, and C. Markopoulos
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx®) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group
Ann Oncol 2002 13: 1737-1742; doi:10.1093/annonc/mdf284 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

J.-L. Merlin, M. Barberi-Heyob, and N. Bachmann
In vitro comparative evaluation of trastuzumab (Herceptin®) combined with paclitaxel (Taxol®) or docetaxel (Taxotere®) in HER2-expressing human breast cancer cell lines
Ann Oncol 2002 13: 1743-1748; doi:10.1093/annonc/mdf263 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Gynecologic tumors Back

J. Sehouli, D. Stengel, G. Oskay, O. Camara, H.-J. Hindenburg, P. Klare, J. Blohmer, G. Heinrich, D. Elling, P. Ledwon, and W. Lichtenegger
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy
Ann Oncol 2002 13: 1749-1755; doi:10.1093/annonc/mdf294 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Gastrointestinal tumors Back

J. Feliu, R. Mel, P. Borrega, L. López Gómez, P. Escudero, J. Dorta, J. Castro, S. E. Vázquez-Estévez, M. Bolaños, E. Espinosa, and M. González Barón
Phase II study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas
Ann Oncol 2002 13: 1756-1762; doi:10.1093/annonc/mdf286 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

J. S. Waters, D. Tait, D. Cunningham, A. R. Padhani, M. E. Hill, S. Falk, F. Lofts, A. Norman, J. Oates, and A. Hill
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus
Ann Oncol 2002 13: 1763-1770; doi:10.1093/annonc/mdf301 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

T. S. Yang, C. H. Wang, R. K. Hsieh, J. S. Chen, and M. C. Fung
Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I–II trial
Ann Oncol 2002 13: 1771-1778; doi:10.1093/annonc/mdf303 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

H. M. Chang, K. H. Jung, T.-Y. Kim, W. S. Kim, H.-K. Yang, K. U. Lee, K. J. Choe, D. S. Heo, Y.-J. Bang, and N. K. Kim
A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer
Ann Oncol 2002 13: 1779-1785; doi:10.1093/annonc/mdf302 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Hematologic malignancies Back

A. Foss Abrahamsen, A. Andersen, O. Nome, A. B. Jacobsen, H. Holte, J. Foss Abrahamsen, and S. Kvaløy
Long-term risk of second malignancy after treatment of Hodgkin’s disease: the influence of treatment, age and follow-up time
Ann Oncol 2002 13: 1786-1791; doi:10.1093/annonc/mdf289 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

T. Saito, Y. Matsuno, R. Tanosaki, T. Watanabe, Y. Kobayashi, and K. Tobinai
{gamma}{delta} T-cell neoplasms: a clinicopathological study of 11 cases
Ann Oncol 2002 13: 1792-1798; doi:10.1093/annonc/mdf293 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Urogenital tumors Back

R. J. Motzer, A. Rakhit, J. Thompson, H. Gurney, P. Selby, R. Figlin, S. Negrier, S. Ernst, M. Siebels, M. Ginsberg, K. Rittweger, and L. Hooftman
Phase II trial of branched peginterferon-{alpha} 2a (40 kDa) for patients with advanced renal cell carcinoma
Ann Oncol 2002 13: 1799-1805; doi:10.1093/annonc/mdf288 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Miscellaneous tumors Back

E. Baudin, C. Docao, C. Gicquel, G. Vassal, A. Bachelot, A. Penfornis, and M. Schlumberger
Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma
Ann Oncol 2002 13: 1806-1809; doi:10.1093/annonc/mdf291 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Phase I and pharmacokinetics Back

D. Rischin, S. P. Ackland, J. Smith, M. B. Garg, S. Clarke, M. J. Millward, G. C. Toner, and J. Zalcberg
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics
Ann Oncol 2002 13: 1810-1818; doi:10.1093/annonc/mdf305 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

P. M. Fracasso, J. S. Rader, R. Govindan, T. J. Herzog, M. A. Arquette, A. Denes, D. G. Mutch, J. Picus, B. R. Tan, C. L. Fears, S. A. Goodner, and S. L. Sun
Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
Ann Oncol 2002 13: 1819-1825; doi:10.1093/annonc/mdf342 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Clinical case Back

M. Ponzoni, M. R. Terreni, F. Ciceri, A. J. M. Ferreri, S. Gerevini, N. Anzalone, M. Valle, S. Pizzolito, and G. Arrigoni
Primary brain CD30+ ALK1+ anaplastic large cell lymphoma (‘ALKoma’): the first case with a combination of ‘not common’ variants
Ann Oncol 2002 13: 1827-1832; doi:10.1093/annonc/mdf300 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Letters to the Editor Back

A. Chehal, J. H. Haidar, R. Jabbour, B. Yammout, and A. Bazarbachi
Obstructive sleep apnea secondary to chronic lymphocytic leukemia
Ann Oncol 2002 13: 1833; doi:10.1093/annonc/mdf277 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

A. Vora, M. Bhutani, A. Sharma, and V. Raina
Severe tumor lysis syndrome during treatment with STI 571 in a patient with chronic myelogenous leukemia accelerated phase
Ann Oncol 2002 13: 1833-1834; doi:10.1093/annonc/mdf304 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

Book reviews Back

M. Rabaglio
P.J. Eifel, C. Levenback (eds). Cancer of the Female Lower Genital Tract
Ann Oncol 2002 13: 1835; doi:10.1093/annonc/mdf210 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

M. Mandalà and S. Barni
A. Manni, M.F. Verderame (eds). Selective Estrogen Receptor Modulators: Research and Clinical Applications
Ann Oncol 2002 13: 1835-1836; doi:10.1093/annonc/mdf292 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.